Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.690
+0.010 (0.60%)
At close: Feb 6, 2026, 4:00 PM EST
1.740
+0.050 (2.96%)
After-hours: Feb 6, 2026, 6:51 PM EST
Daré Bioscience Employees
As of December 31, 2024, Daré Bioscience had 23 total employees, including 21 full-time and 2 part-time employees. The number of employees decreased by 3 or -11.54% compared to the previous year.
Employees
23
Change (1Y)
-3
Growth (1Y)
-11.54%
Revenue / Employee
n/a
Profits / Employee
-$759,302
Market Cap
24.15M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 23 | -3 | -11.54% | 21 | 2 |
| Dec 31, 2023 | 26 | -4 | -13.33% | 23 | 3 |
| Dec 31, 2022 | 30 | 2 | 7.14% | 25 | 5 |
| Dec 31, 2021 | 28 | 5 | 21.74% | 20 | 8 |
| Dec 31, 2020 | 23 | 5 | 27.78% | 16 | 7 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IO Biotech | 78 |
| IGC Pharma | 70 |
| Boundless Bio | 64 |
| Evaxion | 46 |
| Senti Biosciences | 34 |
| Palatin Technologies | 29 |
| Skye Bioscience | 16 |
| BriaCell Therapeutics | 16 |
DARE News
- 2 months ago - DARE to PLAY™ Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States via 503B Outsourcing Facility - GlobeNewsWire
- 2 months ago - Daré Bioscience, Inc. (DARE) Discusses DARE to PLAY Sildenafil Cream as a Treatment Option for Female Genital Arousal Concerns Transcript - Seeking Alpha
- 3 months ago - Daré Bioscience, Inc. (DARE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Daré Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025 - GlobeNewsWire
- 4 months ago - Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research - GlobeNewsWire
- 6 months ago - Daré Bioscience, Inc. (DARE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire